Page last updated: 2024-11-05

ticlopidine and Short Bowel Syndrome

ticlopidine has been researched along with Short Bowel Syndrome in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hadley, G1
Harrison, P1
Adlam, D1
Choudhury, RP1
Droppa, M1
Karathanos, A1
Gawaz, M1
Geisler, T1

Other Studies

2 other studies available for ticlopidine and Short Bowel Syndrome

ArticleYear
Short bowel syndrome and clopidogrel non-responsiveness: a new indication for platelet aggregometry?
    BMJ case reports, 2014, Aug-12, Volume: 2014

    Topics: Adenosine; Aged; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; P

2014
Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting.
    BMJ case reports, 2015, Jul-06, Volume: 2015

    Topics: Abdominal Pain; Anterior Wall Myocardial Infarction; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19;

2015